Detection of MET oncogene/hepatocyte growth factor receptor in lymph node metastases from head and neck squamous cell carcinomas

European Archives of Oto-Rhino-Laryngology

Volumn 254, Issue SUPPL. 1, 1997, Pages

  Galeazzi, E ^a   Olivero, M ^a   Gervasio, F C ^a   De Stefani, A ^a   Valente, G ^a   Comoglio, P M ^a   Di Renzo, M F ^b   Cortesina, G ^a,c  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF SASSARI   (Italy)

^c Clinica ORL   (Italy)

Author keywords

Head and neck squamous cell carcinoma; Hepatocyte growth factor receptor; Lymph node metastases; MET oncogene

Indexed keywords

GROWTH FACTOR RECEPTOR; MONOCLONAL ANTIBODY; PROTEIN TYROSINE KINASE; SCATTER FACTOR; TUMOR MARKER;

BASEMENT MEMBRANE; CANCER CELL CULTURE; CARCINOGENESIS; CELL CULTURE; CELL GROWTH; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVATION; EPITHELIUM; EPITHELIUM CELL; GENE ISOLATION; GROWTH STIMULATION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; LYMPH NODE METASTASIS; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; SQUAMOUS CELL CARCINOMA; SQUAMOUS EPITHELIUM;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; CELLS, CULTURED; COLORING AGENTS; DISEASE PROGRESSION; EPITHELIUM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HEPATOCYTE GROWTH FACTOR; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; LYMPHOID TISSUE; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; ONCOGENES; PHENOTYPE; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MET; RECEPTOR PROTEIN-TYROSINE KINASES; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0031047097     PISSN: 09374477     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02439745     Document Type: Conference Paper

References (26)

1. Akervall JA, Yuesheng J, Wennerberg JP, Zatterstrom UK, Kjellen E, Mertens F, Willen R, Mandahl N, Heim S, Mitelman F (1995) Chromosomal abnormalities involving 11q13 are associated with poor prognosis in patients with squamous cell carcinoma in the head and neck. Cancer 76: 853-859
2. Brakenhoff RH, Van Gog FB, Looney JE, Van Walsum M, Snow GB, Van Dongen GA (1995) Construction and characterization of the chimeric monoclonal antibody E48 for therapy of head and neck cancer. Cancer Immunol Immunother 40: 191-200
3. Brzoska PM, Levin NA, Fu KK, Kaplan MJ, Singer MI, Gray JW, Christman MF (1995) Frequent novel DNA copy number increase in squamous cell head and neck tumours. Cancer Res 55: 3055-3059
4. Bussolino F, Di Renzo MF, Ziehe M, Bocchietto E, Olivero M, Naldini L, Gaudino G, Tamagnone L, Coffer A, Comoglio PM (1992) Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 119: 629-641
5. Clayman GL, El-Naggar AK, Zhang WW, Taylor DL, Roth JA, Goepfert H, Liu TJ (1995) In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma. Cancer Res 55: 1-6
6. Comoglio PM (1993) Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells. Hepatocyte growth factor-scatter factor (HGF-SF) and the c-Met receptor. Birkhauser, Basel, pp 131-165
7. Cortesina G, De Stefani A, Giovarelli M, Barioglio MG, Cavallo GP, Forni G (1988) Treatment of recurrent squamous cell carcinoma of the head and neck with low doses of Interleukin-2 injected perilymphatically. Cancer 62: 2462-2465
8. Cortesina G, De Stefani A, Galeazzi E, Cavallo GP, Badellino F, Margarino G, Jemma C, Forni G (1994) Temporary regression of recurrent squamous cell carcinoma of the head and neck is achieved with low but not with a high dose of recombinant Interleukin-2 injected perilymphatieally. Br J Cancer 69: 572-576
9. Di Renzo MF, Narsimhan RP, Olivero M, Bretti S, Giordano S, Medico E, Gaglia P, Zara P, Comoglio PM (1991) Expression of the Met/HGF receptor in normal and neoplastic human tissues. Oncogens 6: 1997-2003
10. Di Renzo MF, Olivero M, Ferro S, Prat M, Bongarzone I, Pilotti S, Belfiore A, Costantino A, Vigneri R, Pierotti M (1992) Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas. Oncogene 7: 2549-2553
11. Di Renzo MF, Olivero M, Giacomini A, Porte H, Chastre E, Mirossay L, Nordlinger B, Bretti S, Bottardi S, Giordano S, Plebani M, Gespach C, Comoglio PM (1995) Overexpression and amplification of the Met/HGF receptor gene during the progression of colorectal cancer. Clin Cancer Res 1: 147-154
12. El-Naggar AK, Hurr K, Batsakis JG, Luna M, Goepfert H, Huff V (1995) Sequential loss of heterozygosity at microsatellite motifs in preinvasive and invasive head and neck squamous carcinoma. Cancer Res 55: 2656-2659
13. Giordano S, Ponzetto C, Di Renzo MF, Cooper CS, Comoglio PM (1989) Tyrosine kinase receptor indistinguishable from the c-met protein. Nature 339: 155-156
14. Goldberg ID, Rosen EM (eds) (1993) Hepatocyte growth factor-scatter factor (HGF-SF) and the c-Met receptor. Birkhäuser, Basel
15. Irish JC, Bernstein A (1993) Oncogenes in head and neck cancer. Laryngoscope 103: 42-52
16. Meredith SD, Levine PA, Burns JA, Gaffey MJ, Boyd JC, Weiss LM, Erickson NL, Williams ME (1995) Chromosome 11q13 amplification in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 121: 790-794
17. Million RR, Cassisi NJ, Mancuso AA, Stringer SP, Mendenhall WM, Parsons JT (1994) Management of the neck for SCC. Management of head and neck cancer. A multidisciplinary approach. Lippincott, Philadelphia, pp 75-142
18. Modjtahedi H, Eccles S, Sandle J, Box G, Titley J, Dean C (1994) Differentiation or immune destruction: two pathways tor therapy of squamous cell carcinomas with antibodies to the epidermal growth factor receptor. Cancer Res 54: 1695-1701
19. O'Malley BW, Chen SH, Schwartz MR, Woo SL (1995) Adenovirus-mediated gene therapy for human head and neck squamous cell cancer in a nude mouse model. Cancer Res 55: 1080-1085
20. Park M, Dean M, Kaul K, Braun MJ, Gonda MA, Vande Woude G (1987) Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors. Proc Natl Acad Sci USA 84: 6379-6383
21. Prat M, Crepaldi T, Gandino L, Giordano S, Longati P, Comoglio PM (1991) C-terminal truncated forms of Met. the hepatocyte growth factor receptor. Mol Cell Biol 11: 5954-5962
22. Prat M, Narsimhan RP, Crepaldi T, Nicotra MR, Natali PG, Comoglio PM (1991) The receptor encoded by the human c-MET oncogene is expressed in hepatocytes, epithelial cells and solid tumors. Int J Cancer 49: 323-328
23. Rosenberg SA (1988) Immunotherapy of cancer using Interleukin-2. Immunol Today 9: 58-64
24. Schantz SP (1994) Head and neck oncology reasearch. Curr Opin Oncol 6: 265-271
25. Suen JY (1993) Cancer of the neck. Cancer of the head and neck. Churchill Livingstone, London, pp 221-254
26. Weidner KM, Sachs M, Birchmeier W (1993) The Met receptor tyrosine kinase transduces motility, proliferation, and morphogenic signals of scatter factor/hepatocyte growth factor in epithelial cells. J Cell Biol 121: 145-154